Literature DB >> 29143999

MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.

Jin-Mao Li1, Jun Zhou2, Zhen Xu3, Hai-Jin Huang4, Min-Jiang Chen5, Jian-Song Ji5.   

Abstract

MicroRNA (miRNA or miR) has been shown to play an important role in the initiation and development in many different cancers. Here, we demonstrated down-regulated expression of miR-27a-3p in hepatocellular carcinoma (HCC) tissues in comparison with that in adjacent normal liver tissues based on the TCGA database. Cells viability and apoptosis was measured by CCK-8 and flow cytometry assay. Cell invasion and migration was measured by Transwell and wound healing assay. The effect of miR-27a-3p on DUSP16 expression was evaluated by luciferase assays, and western blot assay. miR-27a-3p up-regulation by transfection with miR-27a-3p mimics attenuated SMMC-7721 and HepG2 cell viability, invasion as well as migration, obviously. Moreover, we found that dual specificity phosphatase 16 (DUSP16), also known as mitogen-activated protein kinase phosphatase 7 (MKP-7), is a target of miR-27a-3p. DUSP16 expression was obvious decrease by miR-27a-3p at both transcriptional and protein levels in both SMMC-7721 and HepG2 cells. DUSP16 expression in tissues of HCC was up-regulated in comparison with that in tissues of adjacent liver based on the TCGA database. Overexpression of DUSP16 significantly reversed the cell changes in viability, invasion and migration which resulted from miR-27a-3p up-regulation in SMMC-7721 and HepG2 cells. Our findings contribute to current understanding of the functions of miR-27a-3p and suggest a mechanism by which miR-27a-3p plays an anti-tumor role in the development of HCC by targeting DUSP16.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  DUSP16; hepatocellular carcinoma; invasion; miR-27a-3p; migration; viability

Mesh:

Substances:

Year:  2018        PMID: 29143999     DOI: 10.1002/jcb.26526

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

Review 1.  Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance.

Authors:  Zahra Zandi; Bahareh Kashani; Zivar Alishahi; Atieh Pourbagheri-Sigaroodi; Fatemeh Esmaeili; Seyed H Ghaffari; Davood Bashash; Majid Momeny
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-04       Impact factor: 4.553

2.  LINC01089 is a tumor-suppressive lncRNA in gastric cancer and it regulates miR-27a-3p/TET1 axis.

Authors:  Xufeng Guo; Ming Li
Journal:  Cancer Cell Int       Date:  2020-10-16       Impact factor: 5.722

3.  Hsa-miR-425-5p promotes tumor growth and metastasis by activating the CTNND1-mediated β-catenin pathway and EMT in colorectal cancer.

Authors:  Dingsheng Liu; Hong Zhang; Mingming Cui; Chunsheng Chen; Yong Feng
Journal:  Cell Cycle       Date:  2020-06-28       Impact factor: 4.534

4.  NR4A1 enhances MKP7 expression to diminish JNK activation induced by ROS or ER-stress in pancreatic β cells for surviving.

Authors:  Ze-Qing Pu; Tian-Fu Yu; Dong Liu; Cheng-Wen Jin; Esha Sadiq; Xiaofei Qiao; Xiaojie Li; Yuxuan Chen; Jinsong Zhang; Mingzhong Tian; Siying Li; Ru-Xing Zhao; Xiang-Dong Wang
Journal:  Cell Death Discov       Date:  2021-06-04

5.  Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.

Authors:  Qian Yang; Wen-Wen Gu; Yan Gu; Na-Na Yan; Yan-Yan Mao; Xing-Xing Zhen; Jian-Mei Wang; Jing Yang; Hui-Juan Shi; Xuan Zhang; Jian Wang
Journal:  J Transl Med       Date:  2018-07-04       Impact factor: 5.531

Review 6.  MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations.

Authors:  Jingcheng Zhang; Zhe Cao; Gang Yang; Lei You; Taiping Zhang; Yupei Zhao
Journal:  Front Oncol       Date:  2019-09-12       Impact factor: 6.244

7.  The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma.

Authors:  Zhiqiao Zhang; Jing Li; Tingshan He; Yanling Ouyang; Yiyan Huang; Qingbo Liu; Peng Wang; Jianqiang Ding
Journal:  Cancer Sci       Date:  2019-08-07       Impact factor: 6.716

8.  miR‑27a‑3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells.

Authors:  Hongxin Chen; Binlin Cai; Kun Liu; Qingquan Hua
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

9.  Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.

Authors:  Xi Zhang; Li Ma; Li Zhai; Dong Chen; Yong Li; Zhongjun Shang; Zongmei Zhang; Yanzhang Gao; Wei Yang; Yixun Li; Yuqing Pan
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

10.  Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases.

Authors:  Ming-Fen Li; Jing-Jing Zeng; Ai-Ping Pan; Ying-Hui Lin; Hong-Sheng Lin; Rong-Zhen Zhang; Lei Yang; Yu Zhang; Yi-Wu Dang; Gang Chen
Journal:  Med Sci Monit       Date:  2018-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.